Fig. 1From: Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathwayGLA inhibits the growth of MM cell lines. A The chemical structure of Glaucocalyxin A (GLA). B, C The five MM cell lines (RPMI-8226, LP1, U266, OCI-MY5 and OPM2) were treated with the indicated concentrations of GLA for 24, 48 and 72 h, respectively. MTT assays were used to detect the cell viability. The results are shown as means ± SD from three independent experimentsBack to article page